Group One Trading’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.24M Buy
21,865
+11,233
+106% +$655K ﹤0.01% 2576
2026
Q2
$618K Buy
+10,632
New +$577K ﹤0.01% 3296
2026
Q1
– Sell
-831
Closed -$45.1K – 8461
2025
Q4
$38.3K Buy
+831
New +$37.2K ﹤0.01% 5812
2025
Q1
– Sell
-4,273
Closed -$342K – 8179
2024
Q4
$350K Buy
+4,273
New +$424K ﹤0.01% 3469
2024
Q3
– Sell
-2,473
Closed -$223K – 7182
2024
Q2
$187K Buy
+2,473
New +$168K ﹤0.01% 3452

Other funds holding PCVX

Group One Trading's PCVX Position: Q3 2026 in Review

Group One Trading increased its Vaxcyte (PCVX) stake by 106% in Q3 2026, buying an estimated $655K and bringing the position to 21,865 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #2576.

Group One Trading first reported a position in PCVX in Q2 2024 and has held it in 5 quarters since. 356 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.

  • Group One Trading held 21,865 shares of Vaxcyte worth $1.24M as of Q3 2026.
  • Group One Trading bought 11,233 Vaxcyte shares in Q3 2026, an estimated $655K.
  • Vaxcyte made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #2576 holding.
  • Group One Trading first reported a position in Vaxcyte in Q2 2024 and has held it in 5 quarters since.
  • 356 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.